Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Single Nucleotide Polymorphisms (SNPs) to Classify Subtypes of Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Transplant.

NCT00957736 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT00957736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00957736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Single Nucleotide Polymorphisms (SNPs) to Classify Subtypes of Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Transplant.
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Observational
Overall status
Terminated
Start date
November 30, 2008
Completion date
December 31, 2008
Enrollment
252 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer